Teen Vaccination Rates Continue to Climb, Though Raising Awareness Remains Key
Uptake of Tdap, Meningococcal Vaccines Up More Than 10 Percent
The CDC collected vaccination information from more than 20,000 teenagers ages 13-17. Compared with 2008 figures, coverage for meningococcal conjugate vaccine increased nearly 12 percent to 53.6 percent, and coverage for tetanus, diphtheria and acellular pertussis, or Tdap, vaccine increased nearly 15 percent to 55.6 percent.
The increase in Tdap coverage, in particular, is significant in light of pertussis outbreaks that occurred in several states this year, most notably in California. The California Department of Public Health said in an Aug. 24 report (4-page PDF; About PDFs) that the state has had more than 3,300 reported cases, with at least 169 hospitalizations and eight infant deaths.
"It is important for teens and adults to get a one-time dose of Tdap to protect themselves and those around them from whooping cough," said Anne Schuchat, M.D., director of the CDC's National Center for Immunization and Respiratory Diseases, in an Aug. 19 news release that coincided with the release of the survey results. "Young infants are most vulnerable to serious complications from pertussis and can be infected by older siblings, parents or other caretakers."
Interactive map showing estimated vaccination coverage percentages among adolescents ages 13-17, by state/area and selected vaccine and number of doses, in 2009
MCV = meningococcal conjugate vaccine
Tdap = tetanus, diphtheria, acellular pertussis vaccine
HPV = human papillomavirus vaccine
Source: CDC National Immunization Survey -- Teen, 2009